Mondelez (MDLZ, $66.42) missed Q4 earnings expectations, but beat revenue estimates
Mondelez posted its fourth quarter earnings that missed analysts' expectations, even as revenue surpassed forecasts.
The confectionary giant’s earnings came in at $0.71 a share, below the $0.7187 expected by analysts polled by Investing.com. Revenue of $7.66 billion was above analysts’ expectations of $7.58 billion.
Adjusted operating income of the North America business for the full year 2021 was $1.59 billion, down -10% from a year ago. Sales were up +1.8%.
Looking ahead, Mondelez expects 2022 growth rates to be in line with its long-term objectives of 3% organic revenue and high single-digit adjusted earnings per share growth with free cash topping $3 billion. However, the company mentioned that its outlook was issued “in the context of greater-than-usual volatility as a result of COVID-19”.
CFO Luca Zaramella said that inflationary pressures will persist in 2022.
MDLZ in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 28, 2025
MDLZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 47 cases where MDLZ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MDLZ's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for MDLZ just turned positive on November 19, 2025. Looking at past instances where MDLZ's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDLZ advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Momentum Indicator moved below the 0 level on December 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MDLZ as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDLZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for MDLZ entered a downward trend on December 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.780) is normal, around the industry mean (2.941). P/E Ratio (21.124) is within average values for comparable stocks, (24.483). Projected Growth (PEG Ratio) (5.190) is also within normal values, averaging (7.692). Dividend Yield (0.034) settles around the average of (0.029) among similar stocks. P/S Ratio (1.963) is also within normal values, averaging (1.987).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MDLZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDLZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of packaged food products
Industry FoodSpecialtyCandy
Advertisement